On October 26, 2021 EpiAxis Therapeutics reported that it is among 25 emerging companies that will be showcased at Wholesale Investor’s STEM 2021 Conference on Thursday, October 28 (Press release, EpiAxis Therapeutics, OCT 26, 2021, View Source;utm_medium=rss&utm_campaign=epiaxis-to-present-at-stem-2021-conference [SID1234591924]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Breakthroughs in Science, Technology, Engineering, and Mathematics (STEM) have formed the foundation for critical disruptions across many industries and sectors in the last decade. STEM is the realm where our most significant problems are discovered, and the mechanism whereby these problems can be solved.
EpiAxis recently joined Wholesale Investor, Australasia’s leading investment platform that connects innovative, emerging companies that are looking to raise capital with an active, engaged and growing ecosystem of more than 29,300 high-net-worth investors, fund managers, family offices, PE and VC firms, government bodies and industry participants.
CEO Jeremy Chrisp will present at the Virtual Investor Showcase to raise awareness and visibility for EpiAxis’ epigenetic pipeline of therapies, which work differently to existing – and often toxic – cancer treatments by uniquely reprograming (re-train) the cancer cells back towards normal cells. Chrisp will discuss how our epigenetic science aims to maintain and extend cancer remission, with low side effects.
The showcase includes everything investors need to capitalise on STEM investment opportunities:
25 emerging companies solving problems in the space of; Renewable Energy, Life Sciences, AgriTech, FinTech, Data, and AI
Panel sessions from globally leading STEM investors discussing their due diligence process and sectors of interest
Live Q&A/interaction with panellists
Ability to conduct one-on-one meetings with founders of ventures